LN Future Invest AB, formerly Ellen AB, is a Sweden-based biotechnology company that produces probiotic sanitary protection products for women. The Companyâ€™s main product, Ellen tampon, contains patented natural lacto acid bacteria, Lacto Naturel (LN), and is used for maintaining the vaginal health. The Ellen tampon is made of natural fibers treated with the substance LN, which consists of human lactic acid bacteria, a natural part of healthy women's defense against infections. Ellen AB distributes its products in 37 countries, including Scandinavian countries, France, Germany, Czech Republic, Spain, Portugal, Poland and Belgium, among others.

Employees

Sector

Personal Products

More about the company

Select your edition

All financial news and data tailored to specific country editions

NORTH AMERICA

United-States

Canada

Market Closed - Nasdaq Stockholm 21:00:00 23/02/2026 +04			5-day change	1st Jan Change
0.9250 ^SEK	+6.94%		-.--%	+10.78%

02-25	LN Future Invest AB Reports Earnings Results for the Full Year Ended December 31, 2025	CI
02-16	LN Future Invest AB announces Annual dividend, payable on March 25, 2026	CI

Market Cap	10.25M 1.04M 909K 856K 779K 1.46M 99.83M 1.46M 3.95M 50.85M 3.91M 3.83M 164M	P/E 2024	-8.92x	P/E 2025	1.23x
Enterprise Value	-2.44M -248K -216K -204K -185K -348K -23.75M -348K -940K -12.1M -931K -911K -39.04M	EV / Sales 2024	0.37x	EV / Sales 2025	-0.24x
Free-Float	39.6%	Yield 2024 *	-	Yield 2025	75.4%

02-25	LN Future Invest AB Reports Earnings Results for the Full Year Ended December 31, 2025	CI
02-16	LN Future Invest AB announces Annual dividend, payable on March 25, 2026	CI
01-26	LN Future Invest to Be Delisted from First North, Last Trading Day Set for February 23	FW
01-26	Nasdaq Stockholm to delist LN Future Invest shares on Feb 23	RE
04/09/25	Ln Future Invest begins work on reverse acquisition opportunities	RE
29/08/25	Ln Future Invest H1 net sales at SEK 11.3 mln	RE
29/08/25	LN Future Invest AB Reports Earnings Results for the Half Year Ended June 30, 2025	CI
20/08/25	Ellen Completes Business Transfer to Addeira Pharmaceuticals	FW
10/07/25	Ellen enters into conditional agreement to sell business	RE
09/07/25	Addeira Pharmaceuticals Ab agreed to acquire Business of Ellen AB from Ellen AB (OM:ELN) for SEK 13.3 million.	CI
27/05/25	Ellen Q1 EBITDA Falls To SEK 102,000	RE
28/02/25	Ellen H2 EBIT Loss SEK 1 Mln	RE
28/02/25	LN Future Invest AB Reports Earnings Results for the Full Year Ended December 31, 2024	CI

1 day	+6.94%
Current year	+10.78%

Ellen AB Stock

Stocks

LNFI

SE0014730347

Personal Products

Valuation: Ellen AB

Chart: Ellen AB

Latest news: Ellen AB

Press Releases: Ellen AB

Quotes and Performance

Price Extremes

Managers and Directors: Ellen AB

Sanitary Products

Financials

Company Profile

Current year	0.75	0.92
1 year	0.58	1.19
3 years	0.49	2
5 years	0.49	7.58
10 years	0.49	79

Manager	Title	Age	Since
Sofia Fredrikson CEO	Chief Executive Officer	43	-
Sven Olof Mattsson IRC	Investor Relations Contact	65	01/05/2021
Lena De Wall ADM	Chief Administrative Officer	-	-

Director	Title	Age	Since
Jan Fredrik Mikael Lövgren BRD	Director/Board Member	65	09/07/2004
Sven Olof Mattsson CHM	Chairman	65	01/01/2025
Sofia Fredrikson BRD	Director/Board Member	43	18/09/2025

Add to a list 0 selected To use this feature you must be a member Log in Sign up	Change	5-day change	1-year change	3-year change	Capi.($)
ELLEN AB	+6.94%	-.--%	-15.91%	-18.14%	1.1M
KIMBERLY-CLARK CORPORATION	+0.04%	-1.21%	-21.10%	-21.86%	32.55B
UNICHARM CORPORATION	-1.16%	+0.91%	-1.05%	-46.52%	10.53B
HENGAN INTERNATIONAL GROUP COMPANY LIMITED	+1.02%	-3.86%	-21.84%	-24.76%	2.9B
GILLETTE INDIA LIMITED	-0.45%	-3.53%	-32.07%	+12.43%	2.4B
SOFTCARE LIMITED	-0.41%	-1.43%	-	-	2.3B
CHONGQING BAIYA SANITARY PRODUCTS CO., LTD.	-0.19%	+16.54%	-26.43%	+44.68%	1.36B
C&S PAPER CO.,LTD	+1.43%	+0.57%	-16.67%	-30.26%	1.32B
OIL-DRI CORPORATION OF AMERICA	+1.45%	+4.94%	+41.75%	+190.92%	1.29B
HANGZHOU HAOYUE PERSONAL CARE CO., LTD	+1.17%	+4.38%	-26.08%	-16.47%	789M
Average	+0.98%	+2.11%	-13.27%	+10.00%	5.54B
Weighted average by Cap.	-0.11%	+0.15%	-16.24%	-18.62%

	2024	2025
Net sales	23.48M 2.39M 2.08M 1.96M 1.79M 3.35M 229M 3.35M 9.05M 117M 8.97M 8.77M 376M	14.15M 1.44M 1.25M 1.18M 1.08M 2.02M 138M 2.02M 5.45M 70.19M 5.4M 5.28M 227M
Net income	-1.24M -126K -110K -104K -94.45K -177K -12.1M -177K -479K -6.16M -474K -464K -19.89M	7.51M 763K 666K 627K 571K 1.07M 73.12M 1.07M 2.89M 37.25M 2.87M 2.8M 120M
Net Debt	-2.43M -247K -215K -203K -185K -346K -23.64M -346K -935K -12.04M -927K -906K -38.85M	-12.69M -1.29M -1.12M -1.06M -965K -1.81M -124M -1.81M -4.89M -62.95M -4.85M -4.74M -203M